Hoertkorn Richard Charles Gsk PLC Transaction History

Hoertkorn Richard Charles

$182 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$16.13 - $44.61 $8,290 - $22,929	-514 Reduced 20.02%	2,053 $60,000
Q3 2021 Oct 12, 2021	SELL	$38.79 - $43.16 $7,758 - $8,632	-200 Reduced 7.23%	2,567 $98,000
Q2 2021 Jul 12, 2021	SELL	$36.52 - $41.46 $229,455 - $260,493	-6,283 Reduced 69.43%	2,767 $110,000
Q1 2021 Apr 21, 2021	SELL	$34.27 - $40.01 $68,540 - $80,020	-2,000 Reduced 18.1%	9,050 $323,000
Q4 2020 Jan 29, 2021	SELL	$34.07 - $39.94 $64,733 - $75,886	-1,900 Reduced 14.67%	11,050 $407,000
Q3 2020 Oct 09, 2020	SELL	$38.11 - $42.99 $22,866 - $25,794	-600 Reduced 4.43%	12,950 $487,000
Q2 2020 Jul 27, 2020	SELL	$37.87 - $43.58 $4,355 - $5,011	-115 Reduced 0.84%	13,550 $553,000
Q1 2020 May 01, 2020	SELL	$32.47 - $48.83 $9,741 - $14,649	-300 Reduced 2.15%	13,665 $518,000
Q4 2019 Jan 29, 2020	SELL	$42.0 - $48.25 $75,600 - $86,850	-1,800 Reduced 11.42%	13,965 $656,000
Q3 2019 Oct 24, 2019	SELL	$40.46 - $43.52 $176,405 - $189,747	-4,360 Reduced 21.66%	15,765 $673,000
Q2 2019 Jul 09, 2019	SELL	$39.4 - $42.7 $7,880 - $8,540	-200 Reduced 0.98%	20,125 $805,000
Q1 2019 Apr 30, 2019	SELL	$38.57 - $42.69 $60,747 - $67,236	-1,575 Reduced 7.19%	20,325 $849,000
Q4 2018 Jan 24, 2019	SELL	$37.8 - $42.69 $58,589 - $66,169	-1,550 Reduced 6.61%	21,900 $837,000
Q3 2018 Oct 18, 2018	SELL	$39.75 - $42.69 $35,775 - $38,421	-900 Reduced 3.7%	23,450 $942,000
Q2 2018 Aug 01, 2018	SELL	$39.61 - $42.76 $96,054 - $103,693	-2,425 Reduced 9.06%	24,350 $982,000
Q1 2018 Apr 17, 2018	SELL	$36.18 - $40.15 $770,634 - $855,195	-21,300 Reduced 44.31%	26,775 $1.05 Million
Q4 2017 Jan 25, 2018	BUY	$35.34 - $41.9 $72,447 - $85,895	2,050 Added 4.45%	48,075 $1.71 Million
Q3 2017 Oct 27, 2017	BUY	$39.44 - $41.55 $1.82 Million - $1.91 Million	46,025	46,025 $1.87 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoertkorn Richard Charles, based on Form 13F filings with the SEC.

News

Stay updated on Hoertkorn Richard Charles with notifications on news.

Account